title: Can research at the end of life be a useful tool to advance HIV cure?
authors.affiliation: aUniversity of California, San Diego, La Jolla bCommunity Advisory Board (CAB) AntiViral Research Center (AVRC) cLas Vegas, Nevada dVeterans Affairs San Diego Healthcare System, San Diego, California, USA.
authors.forename: Sara
authors.initials: S
authors.lastname: Gianella
authors.forename: Jeff
authors.initials: J
authors.lastname: Taylor
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Brown
authors.forename: Andy
authors.initials: A
authors.lastname: Kaytes
authors.forename: Cristian L
authors.initials: CL
authors.lastname: Achim
authors.forename: David J
authors.initials: DJ
authors.lastname: Moore
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Little
authors.forename: Ronald J
authors.initials: RJ
authors.lastname: Ellis
authors.forename: Davey M
authors.initials: DM
authors.lastname: Smith
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D035843:Biomedical Research / Q000379:methods* / Q000639:trends; D002986:Clinical Trials as Topic; D006678:HIV / Q000187:drug effects / Q000254:growth & development*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D019452:Terminally Ill; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D019380:Anti-HIV Agents